Galvanize Therapeutics: $100 Million Raised For Advancing Therapies For Cancer And Chronic Lung Disease
By Amit Chowdhry ● Sep 6, 2025
Galvanize Therapeutics, a commercial-stage medical technology company developing novel pulsed electric field therapies, has announced the successful close of a $100 million Series C financing round. The round was oversubscribed, reflecting strong investor confidence in the company’s vision and progress. Led by Sofinnova Partners, the funding round also included Norwest Venture Partners, Elevage Medical Technologies, Ally Bridge Group, Perceptive Xontogeny Venture Fund, Janus Henderson Investors, and Longaeva. Several existing investors also returned to participate, including Fidelity Management & Research Company, T. Rowe Price, Gilmartin Capital, Intuitive Surgical, and Apple Tree Partners, which initially seeded the company.